Back to Agenda
Keynote Speech 2: History and Future of ICH
Session Chair(s)
Tatsuo Kurokawa, DIAFellow, PhD
Director General
The Japan Biosimilar Association, Japan
Keynote Speech 2: The History and Future of ICH Activity Based on 20 Years Experience
Speaker(s)
History and Future of ICH
Fernand Sauer, PharmD, LLM
French Academy of Pharmacy; Former Executive Director EMA, France
Have an account?